These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15985940)

  • 21. Attitudes of psychiatrists toward antipsychotic depot medication.
    Heres S; Hamann J; Kissling W; Leucht S
    J Clin Psychiatry; 2006 Dec; 67(12):1948-53. PubMed ID: 17194274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attitudes towards long-acting depot antipsychotics: a survey of patients, relatives and psychiatrists.
    Jaeger M; Rossler W
    Psychiatry Res; 2010 Jan; 175(1-2):58-62. PubMed ID: 20004980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adherence to depot versus oral antipsychotic medication in schizophrenic patients during the long-term therapy.
    Stanković Z; Ille T
    Vojnosanit Pregl; 2013 Mar; 70(3):267-73. PubMed ID: 23607237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How much more effective do depot antipsychotics have to be compared to oral antipsychotics before they are prescribed?
    Hamann J; Mendel R; Heres S; Leucht S; Kissling W
    Eur Neuropsychopharmacol; 2010 Apr; 20(4):276-9. PubMed ID: 20133108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic review of patient and nurse attitudes to depot antipsychotic medication.
    Walburn J; Gray R; Gournay K; Quraishi S; David AS
    Br J Psychiatry; 2001 Oct; 179():300-7. PubMed ID: 11581109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of atypical antipsychotics in the management of schizophrenia.
    Campbell M; Young PI; Bateman DN; Smith JM; Thomas SH
    Br J Clin Pharmacol; 1999 Jan; 47(1):13-22. PubMed ID: 10073734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and delivery of a quality improvement program to reduce antipsychotic polytherapy.
    Gören JL; Beck SE; Mills BJ; Shtasel DL; Dufresne RL
    J Manag Care Pharm; 2010; 16(6):393-401. PubMed ID: 20635830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Olanzapine versus other atypical antipsychotics for schizophrenia.
    Komossa K; Rummel-Kluge C; Hunger H; Schmid F; Schwarz S; Duggan L; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2010 Mar; (3):CD006654. PubMed ID: 20238348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An audit of outpatient antipsychotic usage in the three health sectors of Auckland, New Zealand.
    Humberstone V; Wheeler A; Lambert T
    Aust N Z J Psychiatry; 2004 Apr; 38(4):240-5. PubMed ID: 15038803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics.
    Sikirica V; Pliszka SR; Betts KA; Hodgkins P; Samuelson T; Xie J; Erder H; Dammerman R; Robertson B; Wu EQ
    J Manag Care Pharm; 2012; 18(9):676-89. PubMed ID: 23206211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The provision of physical health care by nurses to young people with first episode psychosis: A cross-sectional study.
    Chee GL; Wynaden D; Heslop K
    J Psychiatr Ment Health Nurs; 2018 Sep; 25(7):411-422. PubMed ID: 29904970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and tolerability: how do newer generation "atypical" antipsychotics compare?
    Tandon R
    Psychiatr Q; 2002; 73(4):297-311. PubMed ID: 12418358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perceptions of relapse risks following first-episode psychosis and attitudes towards maintenance medication: a comparison between nursing and social work professionals.
    Chan KK; Chin QP; Tang JY; Longenecker J; Hui CL; Chiu CP; Lam MM; Wong GH; Chen EY
    Early Interv Psychiatry; 2011 Nov; 5(4):324-34. PubMed ID: 21521490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bromperidol decanoate (depot) for schizophrenia.
    Purgato M; Adams CE
    Cochrane Database Syst Rev; 2011 Sep; (9):CD001719. PubMed ID: 21901678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychiatric nurses' attitudes towards patient autonomy in depot clinics.
    Svedberg B; Lützén K
    J Adv Nurs; 2001 Aug; 35(4):607-15. PubMed ID: 11529961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-acting formulations of atypical antipsychotics: time to reconsider when to introduce depot antipsychotics.
    Chue P; Emsley R
    CNS Drugs; 2007; 21(6):441-8. PubMed ID: 17521224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Choosing antipsychotic maintenance therapy--a naturalistic study.
    Tavcar R; Dernovsek MZ; Zvan V
    Pharmacopsychiatry; 2000 Mar; 33(2):66-71. PubMed ID: 10761822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morale and job perception of community mental health professionals in Berlin and London.
    Priebe S; Fakhoury WK; Hoffmann K; Powell RA
    Soc Psychiatry Psychiatr Epidemiol; 2005 Mar; 40(3):223-32. PubMed ID: 15742228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychiatric nurses' attitudes to antipsychotic depots in Hong Kong and comparison with London.
    Patel MX; Yeung FK; Haddad PM; David AS
    J Psychiatr Ment Health Nurs; 2008 Nov; 15(9):758-66. PubMed ID: 18844802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Switching from depot antipsychotic drugs to olanzapine in patients with chronic schizophrenia.
    Godleski LS; Goldsmith LJ; Vieweg WV; Zettwoch NC; Stikovac DM; Lewis SJ
    J Clin Psychiatry; 2003 Feb; 64(2):119-22. PubMed ID: 12633119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.